BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15816390)

  • 21. Bladder cancer in a 39-year-old female pharmacist.
    Levin LI; Holly EA; Seward JP
    J Natl Cancer Inst; 1993 Jul; 85(13):1089-91. PubMed ID: 8515497
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclophosphamide-induced urinary bladder cancer: a case report.
    Shuin T; Kubota Y
    Jpn J Clin Oncol; 1983 Mar; 13(1):75-80. PubMed ID: 6834654
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-induced bladder carcinoma.
    Uyama T; Nakamura S; Moriwaki S
    Urology; 1981 Oct; 18(4):355-8. PubMed ID: 7292813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival and late development of bladder cancer in renal transplant patient with progressive multifocal leukoencephalopathy.
    Embrey JR; Silva FG; Helderman JH; Peters PC; Sagalowsky AI
    J Urol; 1988 Mar; 139(3):580-1. PubMed ID: 3278140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder cancer in patients undergoing haemodialysis.
    Morey A; Marco J; Alarcón A; Bestard J; Gascó J
    Br J Urol; 1993 Jun; 71(6):761. PubMed ID: 8343911
    [No Abstract]   [Full Text] [Related]  

  • 27. Bladder cancer following low or high dose pelvic irradiation.
    Quilty PM; Kerr GR
    Clin Radiol; 1987 Nov; 38(6):583-5. PubMed ID: 3690959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
    Eblin KE; Bredfeldt TG; Gandolfi AJ
    Toxicology; 2008 Jun; 248(2-3):67-76. PubMed ID: 18456381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transitional cell carcinoma urinary bladder manifesting as second malignancy following radiotherapy for carcinoma cervix.
    Dey S; Philipraj JS;
    Indian J Cancer; 2009; 46(1):71-2. PubMed ID: 19282572
    [No Abstract]   [Full Text] [Related]  

  • 30. Bladder cancer following upper tract urothelial carcinoma.
    Kauffman EC; Raman JD
    Expert Rev Anticancer Ther; 2008 Jan; 8(1):75-85. PubMed ID: 18095885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two extrapulmonary neoplasms in a uranium miner.
    Roemer HC; Golka K; Schulze H; Loehlein D
    J R Soc Med; 2002 Jun; 95(6):302. PubMed ID: 12042381
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.
    Smaldone MC; Jacobs BL; Smaldone AM; Hrebinko RL
    Urology; 2008 Sep; 72(3):613-6. PubMed ID: 18554696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?
    Mazhar D; Ali N; Ngan S
    Future Oncol; 2007 Feb; 3(1):5-8. PubMed ID: 17280495
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy-induced bladder cancer.
    Nilsson S; Ullén A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):89-92. PubMed ID: 18815922
    [No Abstract]   [Full Text] [Related]  

  • 35. Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice.
    Hursting SD; Perkins SN; Lavigne JA; Beltran L; Haines DC; Hill HL; Alvord WG; Barrett JC; DiGiovanni J
    Mol Carcinog; 2009 Aug; 48(8):671-7. PubMed ID: 19415693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transitional cell carcinoma arising from bladder left behind.
    Asano S; Matsuda M; Takemoto M; Osafune M; Sagawa S
    Eur Urol; 1979; 5(3):223-4. PubMed ID: 446500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications of intravesical therapy for urothelial cancer of the bladder.
    Koya MP; Simon MA; Soloway MS
    J Urol; 2006 Jun; 175(6):2004-10. PubMed ID: 16697786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urothelial carcinoma with abundant myxoid stroma.
    Tavora F; Epstein JI
    Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occupational urothelial cancer in a former iron foundry worker.
    Cohen NP; Thomas DM
    Br J Urol; 1992 Jul; 70(1):95. PubMed ID: 1638380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.